tiprankstipranks
Dr. Reddy's Laboratories Ltd (RDY)
NYSE:RDY
US Market
RDY
Dr Reddy's Laboratories
RESEARCH TOOLSreports
Want to see RDY full AI Analyst Report?

Dr Reddy's Laboratories (RDY) Financial Statements

450 Followers

Dr Reddy's Laboratories Financial Overview

Dr Reddy's Laboratories's market cap is currently $10.89B. The company's EPS TTM is $0.158; its P/E ratio is 21.72; and it has a dividend yield of 0.64%. Dr Reddy's Laboratories is scheduled to report earnings on January 27, 2026, and the estimated EPS forecast is $0.13. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 325.54B₹ 279.16B₹ 245.88B₹ 214.39B₹ 2.56B
Gross Profit₹ 190.43B₹ 163.61B₹ 139.34B₹ 113.84B₹ 1.30B
Operating Income₹ 71.84B₹ 67.73B₹ 57.14B₹ 29.48B₹ 431.44M
EBITDA₹ 96.67B₹ 88.42B₹ 74.43B₹ 45.08B₹ 534.77M
Net Income₹ 56.54B₹ 55.68B₹ 45.07B₹ 23.57B₹ 232.21M
Balance Sheet
Cash & Short-Term Investments₹ 57.91B₹ 81.47B₹ 61.80B₹ 44.37B₹ 472.87M
Total Assets₹ 492.99B₹ 387.52B₹ 321.85B₹ 292.83B₹ 3.63B
Total Debt₹ 46.77B₹ 20.02B₹ 13.47B₹ 33.84B₹ 414.53M
Net Debt₹ 32.11B₹ 12.91B₹ 7.69B₹ 18.99B₹ 211.71M
Total Liabilities₹ 155.82B₹ 106.97B₹ 90.86B₹ 102.30B₹ 1.26B
Stockholders' Equity₹ 333.39B₹ 280.55B₹ 230.99B₹ 190.53B₹ 2.37B
Cash Flow
Free Cash Flow₹ 12.03B₹ 18.00B₹ 40.01B₹ 9.06B₹ 23.14B
Operating Cash Flow₹ 46.43B₹ 45.43B₹ 58.88B₹ 28.11B₹ 35.70B
Investing Cash Flow₹ -58.08B₹ -40.28B₹ -41.37B₹ -26.39B₹ -22.66B
Financing Cash Flow₹ 18.91B₹ -3.76B₹ -26.86B₹ -2.42B₹ -298.00M
Currency in INR

Dr Reddy's Laboratories Earnings and Revenue History

Income Statement >

Dr Reddy's Laboratories Debt to Assets

Balance Sheet >

Dr Reddy's Laboratories Cash Flow

Cash Flow >

Dr Reddy's Laboratories Forecast EPS vs Actual EPS

Earnings >